| Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
|---|---|---|---|---|---|---|
| Q4 2023 | 134 | 321,105 | AAPL, AMZN, GMED, JNJ | 13F-HR | 2/8/2024 | 000170113224000001 |
| Q3 2023 | 133 | 286,501 | AAPL, JNJ, AMZN, GMED | 13F-HR | 11/6/2023 | 000170113223000004 |
| Q2 2023 | 138 | 302,441 | AAPL, JNJ, GMED, AMZN | 13F-HR | 8/3/2023 | 000170113223000003 |
| Q1 2023 | 133 | 296,498 | AAPL, JNJ, GMED, DVY | 13F-HR | 4/25/2023 | 000170113223000002 |
| Q4 2022 | 138 | 279,464 | AAPL, GMED, JNJ, DVY | 13F-HR | 2/6/2023 | 000170113223000001 |
| Q3 2022 | 143 | 267,052 | AAPL, GMED, JNJ, AMZN | 13F-HR | 11/3/2022 | 000170113222000004 |
| Q2 2022 | 594 | 290,667 | AAPL, GMED, JNJ, IYY | 13F-HR | 8/4/2022 | 000170113222000003 |
| Q1 2022 | 616 | 352,585 | AAPL, GMED, JNJ, GLD | 13F-HR | 5/3/2022 | 000170113222000002 |
| Q4 2021 | 595 | 355,172 | AAPL, GMED, JNJ, AMZN | 13F-HR | 2/2/2022 | 000170113222000001 |
| Q3 2021 | 596 | 336,304 | AAPL, GMED, AMZN, JNJ | 13F-HR | 11/9/2021 | 000170113221000006 |
| Q2 2021 | 566 | 341,883 | AAPL, GMED, AMZN, JNJ | 13F-HR | 7/29/2021 | 000170113221000005 |
| Q1 2021 | 536 | 309,878 | AAPL, GMED, AMZN, JNJ | 13F-HR | 5/4/2021 | 000170113221000003 |
| Q4 2020 | 467 | 294,508 | AAPL, GMED, AMZN, JNJ | 13F-HR | 1/21/2021 | 000170113221000001 |
| Q3 2020 | 454 | 259,631 | AAPL, GMED, AMZN, JPST | 13F-HR | 10/26/2020 | 000170113220000004 |
| Q2 2020 | 448 | 241,246 | AAPL, GMED, AMZN, JNJ | 13F-HR | 7/24/2020 | 000170113220000003 |
| Q1 2020 | 424 | 189,232 | AAPL, GMED, AMZN, JPST | 13F-HR | 4/30/2020 | 000170113220000002 |
| Q4 2019 | 427 | 217,630 | GMED, AAPL, JNJ, AMZN | 13F-HR | 2/10/2020 | 000170113220000001 |
| Q3 2019 | 437 | 195,715 | GMED, AAPL, JPST, JNJ | 13F-HR | 10/15/2019 | 000170113219000004 |
| Q2 2019 | 434 | 195,454 | GMED, AAPL, JPST, ITOT | 13F-HR | 8/6/2019 | 000170113219000003 |
| Q1 2019 | 426 | 196,283 | AAPL, JPST, ITOT, GMED | 13F-HR | 5/1/2019 | 000170113219000002 |
| Q4 2018 | 425 | 169,893 | AAPL, JPST, ITOT, GMED | 13F-HR | 1/18/2019 | 000170113219000001 |
| Q3 2018 | 442 | 190,279 | AAPL, JPST, GMED, ITOT | 13F-HR | 11/9/2018 | 000170113218000004 |
| Q2 2018 | 406 | 169,353 | AAPL, GMED, ITOT, PFF | 13F-HR | 7/26/2018 | 000170113218000003 |
| Q1 2018 | 381 | 162,797 | AAPL, GMED, ITOT, PFF | 13F-HR | 4/23/2018 | 000170113218000002 |
| Q4 2017 | 353 | 161,283 | AAPL, GMED, ITOT, PFF | 13F-HR | 1/29/2018 | 000170113218000001 |
| Q3 2017 | 350 | 150,890 | AAPL, PFF, ITOT, GMED | 13F-HR | 11/3/2017 | 000170113217000005 |
| Q2 2017 | 381 | 149,862 | AAPL, PFF, GMED, ITOT | 13F-HR | 8/9/2017 | 000150987317000006 |
| Q1 2017 | 331 | 139,084 | AAPL, PFF, ITOT, GMED | 13F-HR | 5/15/2017 | 000170113217000004 |
| Q4 2016 | 309 | 124,933 | AAPL, PFF, ITOT, GMED | 13F-HR | 5/12/2017 | 000170113217000003 |